You have 9 free searches left this month | for more free features.

tilelimumab

Showing 1 - 1 of 1

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tislelizumab, Locally Advanced Rectal Cancer, Total Neoadjuvant Treatment Trial in Changchun (Tilelimumab)

Not yet recruiting
  • Tislelizumab
  • +3 more
  • Tilelimumab
  • Changchun, Jilin, China
    First Hospital of Jilin University
May 26, 2021